Cuba Develops and Shares Cancer Vaccine with World

October 31, 2016
One of the main benefits of the new relations between Cuba and the United States will be the appearance of a new lung cancer vaccine that was developed and tested by Cuban doctors.

Do you remember when the idea of a cancer vaccine was science fiction? Every day we get closer and closer to reaching this goal. The best scientists in the world are concentrating their efforts into putting an end to this devastating disease.

Now, every country on earth is sharing its resources to find treatments and a cure for the disease. The best minds in the world are working together to achieve this goal.

The developing relations between the United States and Cuba are proof of this. There is surprising news of a new agreement and a good relationship between the U.S. and Cuba.

The two nations have agreed to share information to create the first cancer vaccine ever. Cuban doctors developed it to reduce the risk of complications from lung cancer.

You might like: Scientific Advances Develop Vaccine Against Cancerous Tumors

However, it is not a preventative medicine or a cure. It does slow down its development, however, so that the disease becomes chronic, instead of terminal.

This would make chemotherapy and radiation unnecessary. This way some of the worst parts about cancer could be avoided. This has been one of the hardest parts of cancer to deal with, although it has become more bearable with advancing science and new partnerships.

The Surprising New Lung Cancer Vaccine

Lung cancer

According to the project’s director, Fernando Ravsberg, the vaccine offers many new advantages.

All tumors have a very particular feature in common. They contain a molecule that’s essential for their growth. The vaccine works by fighting this molecule, preventing the cancer from developing further.

Vaccination will improve the quality of life of those who suffer lung cancer. Anyone who has ever suffered from cancer, either directly or indirectly, knows how important this is.

When the disease reaches advanced stages, the patient’s quality of life deteriorates exponentially, so much so that some people choose to discontinue treatment.

Cuba is already providing its citizens with access to the vaccine. For foreigners, however, politics make things more complicated, but it is still possible for those from other countries to receive this treatment.

The first step to take is to contact Servimed to enter Cuba’s healthcare system.

You might like: The Secret of the Cancerless Village

The First Cancer Vaccine in the World

Woman with cancer

Despite the complications involving relations with Cuba, the vaccine is already available in Peru and Paraguay.

Europe is also using it in several clinical trials, although this is really costly. In addition, it delays the availability of the vaccine in this region by 3 or 4 years. Meanwhile, Cuban doctors are searching for foreign investors to finance it.

In this sense, it has opened up the possibility of new or improved relations between Cuba and other world powers.

Einar Blanco, from the Cuban Center for Molecular Immunology (CMI), affirms that this will be much easier thanks to the new laws on foreign investment in Cuba.

The new act allows the CMI to sign agreements with partners in other countries. Contracts may be issued for any phase: research, production or commercialization.

They will also have access to the Mariel free trade zone, a huge port to be set aside for industrial development on the island.

A Ray of Hope

The availability of a treatment like this will make a difference in the lives of thousands of people.

It’s not just about staying alive, it’s about maintaining a dignified life while going through the difficulties that all those with a chronic disease experience. The quality of life after being diagnosed with cancer is often abysmal.

Cancer vaccine syringe

The first cancer vaccine will serve as an inspiration for more to come.

Scientists will be able to develop similar treatments for other organs by following the same processes used to create the vaccine against lung cancer. Doctors have reacted enthusiastically to the news.

Remember that it’s estimated that 40% of people are at risk of developing some form of cancer during their lifetime.

Because it’s the number one cause of death in the world, discouragement in both doctor and patient is understandable. However, this new vaccine against lung cancer is a breath of fresh air.

  • Rodríguez, P. C., Rodríguez, G., González, G., & Lage, A. (2010). Clinical development and perspectives of CIMAvax EGF, Cuban vaccine for non-small-cell lung cancer therapy. MEDICC review12(1), 17-23.
  • Holt, G. E., Podack, E. R., & Raez, L. E. (2011). Immunotherapy as a strategy for the treatment of non-small-cell lung cancer. Therapy8(1), 43.